Attenuation of limb loss in an experimentally induced hindlimb ischemic model by fibroblast growth factor-2/fragmin/protamine microparticles as a delivery system

Tissue Engineering - Part A

Volumn 18, Issue 21-22, 2012, Pages 2239-2247

  Nakamura, Shingo ^a   Ishihara, Masayuki ^a   Takikawa, Megumi ^a   Kishimoto, Satoko ^a   Isoda, Susumu ^a   Fujita, Masanori ^a   Sato, Masahiro ^b   Maehara, Tadaaki ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIODEGRADABLE CARRIERS; BLOOD FLOW; CONTROLLED RELEASE; CYTOKINES; DELIVERY SYSTEMS; FIBROBLAST GROWTH FACTOR-2; HIND LIMBS; HISTOLOGICAL EVALUATION; INTRAMUSCULAR INJECTIONS; MALE MOUSE; MICRO-PARTICLES; OXYGEN SATURATION; PARTIAL RECOVERY; PHOSPHATE-BUFFERED SALINES; SURFACE TEMPERATURES; THERAPEUTIC TREATMENTS; TURBID SUSPENSIONS;

ATMOSPHERIC TEMPERATURE; MAMMALS;

RECOVERY;

MUS;

DALTEPARIN; FIBROBLAST GROWTH FACTOR 2; MICROSPHERE; OXYGEN; PROTAMINE;

ANGIOGENESIS; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CAPILLARY; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG EFFECT; HINDLIMB; ISCHEMIA; LIMB SALVAGE; MALE; METABOLISM; MOUSE; MUSCLE; PATHOLOGY; PERFUSION; THERMOGRAPHY; TIME; VASCULARIZATION;

ANIMALS; CAPILLARIES; DALTEPARIN; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; FIBROBLAST GROWTH FACTOR 2; HINDLIMB; ISCHEMIA; LIMB SALVAGE; MALE; MICE; MICE, INBRED BALB C; MICROSPHERES; MUSCLES; NEOVASCULARIZATION, PHYSIOLOGIC; OXYGEN; PERFUSION; PROTAMINES; THERMOGRAPHY; TIME FACTORS;

EID: 84868519105     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0741     Document Type: Article

References (36)

1. Abraham, J.A., Mergia, J., Whang, L., Tumolo, A., Friedman, J., Hjerrild, K.A., Gospodarowicz, D., and Fiddes, J.C. Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science 234, 545, 1986.
2. Takeshita, S., Tsurumi, Y., Couffinahal, T., Asahara, T., Bauters, C., Symes, J., Ferrara, N., and Isner, J.M. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest 75, 487, 1996.
3. VanBelle, E., Witzenbichler, B., Chen, D., Silver, M., Chang, L., Schwall, R., and Isner, J.M. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor. The case for paracrine amplification of angiogenesis. Circulation 97, 381, 1998.
4. Kocher, A.A., Schuster, M.D., Szabolcs, M.J., Takuma, S., Burkhoff, D., Wang, J., Homma, S., Edwards, N.M., and Itescu, S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardio-myocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7, 430, 2001.
5. Fuchs, S., Baffour, R., Zhou, Y.F., Shou, M., Pierre, A., Tio, F.O., Weissman, N.J., Leon, M.B., Epstein, S.E., and Kornowski, R. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 37, 1726, 2001.
6. Nakamura, S., Kanatani, Y., Kishimoto, S., Nakamura, S.-I., Ohno, C., Horio, T., Fujita, M., Hattori, H., Tanaka, Y., Kiyosawa, T., Maehara, T., and Ishihbara, M. Controlled release of FGF-2 using fragmin/protamine microparticles and effect on neovascularization. J Biomed Mater Res 91A, 814, 2009.
7. Pittenger, M.F., and Martin, B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95, 9, 2004.
8. Kalka, C., Masuda, H., Takahashi, T., Kalka-Moll, W.M., Silver, M., Kearney, M., Li, T., Isner, J.M., and Asahara, T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97, 3422, 2000.
9. Shyu, K.G., Manor, O., Magner, M., Yancopoulos, G.D., and Isner, J.M. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation 98, 2081, 1998.
10. Taniyama, Y., Morishita, R., Aoki, M., Nakagami, H., Yamamoto, K., Yamazaki, K., Matsumoto, K., Nakamura, T., Kaneda, Y., and Ogihara, T. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hind limb ischemia models: preclinical study for treatment of peripheral arterial disease. Gene Ther 8, 181, 2001.
11. Morishita, R., Makino, H., Aoki, M., Hashiya, N., Yamasaki, K., Azuma, J., Taniyama, Y., Sawa, Y., Kaneda, Y., and Ogihara, T. Phase I/IIa clinical trial of therapeutic angiogenesis using hepatocyte growth factor gene transfer to treat critical limb ischemia. Arterioscler Thromb Vasc Biol 31, 713, 2011
12. Cote, M.F., Laroche, G., Gagnon, E., Chevallier, P., and Doillon, C.J. Denatured collagen as support for a FGF-2 delivery system: physicochemical characterizations and in vitro release kinetics and bioactivity. Biomaterials 25, 3761, 2004.
13. Young, S., Wong, M., Tabata, Y., and Mikos, A.G. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release 109, 256, 2005.
14. DeBlois, C., Cote, M.F., and Doillon, C.J. Heparin-fibroblast growth factor-fibrin complex: in vitro and in vivo applications to collagen-based materials. Biomaterials 15, 665, 1994.
15. Tanihara, M., Suzuki, Y., Yamamoto, E., Noguchi, A., and Mizushima, Y. Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginate. J Biomed Mater Res 56, 216, 2001.
16. Ornitz, D. M., and Itoh, N. Fibroblast growth factors. Genome Biol 2, 3005.1, 2001.
17. Canalis, E., Centrella, M., and McCarthy, T. Effects of basic fibroblast growth factor on bone formation in vitro. J Clin Invest 81, 1572, 1988.
18. Nakajima, F., Ogasawara, A., Goto, K., Moriya, H., Ninomiya, Y., Einhorn, T.A., and Yamazaki, M. Spatial and temporal gene expression in chondrogenesis during fracture healing and the effects of basic fibroblast growth factor. J Orthop Res 19, 935, 2001.
19. Tsuboi, R., and Rifkin, D.B. Recombinant basic fibroblast growth factor stimulates wound healing in healing-impairing db/db mice. J Exp Med 172, 245, 1990.
20. Ishihara, M., and Ono, K. Structure and function of heparin and heparan sulfate: heparinoid library and modification of FGF-activities. Trend Glycosci Glycotech 10, 223, 1998.
21. Ishihara, M. Biosynthesis, structure, and biological activity of basic FGF binding domains of heparan sulfate. Trend Glycosci Glycotech 5, 343, 1993. (Pubitemid 24776835)
22. Salmivirta, M., Lidholt, K., and Lindahl, U. Heparan sulfate: a piece of information. FASEB J 10, 1270, 1996.
23. Lindahl, U., Lidholt, K., Spillmann, D., and Kjellen, L. More to "heparin" than anti-coagulation. Thromb Res 75, 1, 1994.
24. Ishihara, M., Obara, K., Ishizuka, T., Fujita, M., Sato, M., Masuoka, K., Saito, Y., Yura, H., Matsui, T., Hattori, H., Kikuchi, M., and Kurita, A. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization. J Biomed Mater Res 64A, 551, 2003.
25. Hirsh, J., Warkentin, T.E., Shaughnessy, S.G., Anand, S.S., Halperin, J.L., Raschke, R., Granger, C., Ohman, E.M., and Dalen, J.E. Heparin and low-molecular-weight heparin, mechanisms of action, phormacokinetics, dosing, monitoring, efficacy, and safety. Chest 119, 64S, 2001.
26. Wolzt, M., Weltermann, A., Nieszpaur-Los, M., Schneider, B., Fassolt, A., Lechner, K., Eichler, H.G., and Kyrle, P.A. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (FragminR) at the site of activation of the coagulation system in man. Thromb Haemost 73, 439, 1995.
27. Pan, M., Suarez de Lezo, J., Medina, A., Romero, M., Hernandez, E., Segura, J., Melian, F., Wanguemert, F., Landin, M., Benitez, F., Amat, M., Velasco, F., and Torres, A. Inlaboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation. Am J Cardiol 80, 1336, 1997.
28. Couffinhal, T., Silver, M., Zheng, L.P., Kearney, M., Witzenbichler, B., and Isner, J.M. Mouse model of angiogenesis. Am J Pathol 152, 1667, 1998.
29. Cho, S.W., Moon, S.H., Lee, S.H., Kang, S.W., Kim, J., Lim, J.M., Kim, H.S., Kim, B.S., and Chung, H.M. Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation 116, 2409, 2007.
30. Fujita, M., Ishihara, M., Shimizu, M., Obara, K., Nakamura, S., Kanatani, Y., Morimoto, Y., Takase, B., Matsui, T., Kikuchi, M., and Maehara, T. Therapeutic angiogenesis induced by controlled release of fibroblast growth factor-2 from injectable chitosan/non-anticoagulant heparin hydrogel in a rat hindlimb ischemia model. Wound Repair Regen 15, 58, 2007.
31. Ring, F.J. Thermal imaging today and its relevance to diabetes. Diabetes Sci Technol 4, 857, 2010.
32. Nakamura, S., Kishimoto, S., Nakamura, S.-I., Nambu, M., Fujita, M., Tanaka, Y., Mori, Y., Tagawa, M., Maehara, T., and Ishihara, M. Fragmin/protamine microparticles as cell carriers to enhance viability of adipose-derived stromal cells and their subsequent effect on in vivo neovascularization. J Biomed Mater Res 92A, 1614, 2010.
33. Fukino, K., Sata, M., Seko, Y., Hirata, Y., and Nagai, R. Genetic background influences therapeutic effectiveness of VEGF. Biochem Biophys Res Commun 310, 143, 2003.
34. Kishimoto, S., Nakamura, S., Nakamura, S.-I., Kanatani, Y., Hattori, H., Tanaka, Y., Harada, Y., Tagawa, M., Mori, Y., Maehara, T., and Ishihara, M. Fragmin/protamine microparticle-coated matrix immobilized cytokines to stimulate various cell proliferations with low serum media. Artif Organs 33, 431, 2009.
35. Horio, T., Fujita, M., Tanaka, Y., Ishihara, M., Kishimoto, S., Nakamura, S., Hase, K., and Maehara, T. Efficacy of fragmin/protamine microparticles containing fibroblast growth factor-2 (F/P MPs/FGF-2) to induce collateral vessels in a rabbit model of hindlimb ischemia. J Vasc Surg 54, 791, 2011.
36. Marui, A., Kanematsu, A., Yamahara, K., Doi, K., Kushibiki, T., Yamamoto, M., Itoh, H., Ikeda, T., Tabata, Y., and Komeda, M. Simultaneous application of basic fibroblast growth factor and hepatocyte growth factor to enhance the blood vessels formation. J Vasc Surg 41, 82, 2005.